Eye-Tracking Shows Promise for Early Autism Detection in Infants

Eye-Tracking as a Screening Tool

Recent advances in eye-tracking technology are offering new hope for early autism detection. A 2025 study published in Springer involving 585 toddlers aged 7-48 months found that brief eye-tracking protocols could be successfully implemented in nursery settings to identify children at risk for autism spectrum disorder (ASD). The study used standardized stimuli showing social interactions while measuring gaze duration and fixation patterns.

This builds on earlier work showing that infants who later receive ASD diagnoses often show distinct gaze patterns when viewing social scenes, such as reduced attention to eyes and increased focus on mouths or background objects. A 2022 Nature study validated these eye-tracking biomarkers at large scale, while a 2024 Nature paper demonstrated the feasibility of ultra-brief (2-minute) screening protocols.

Why Earlier Detection Matters

Early identification of autism can lead to earlier intervention, which research shows can significantly improve outcomes. The current average age of diagnosis in the U.S. remains around 4 years old, despite the fact that behavioral signs often emerge much earlier. This delay means children miss critical windows for early support services. The new eye-tracking approaches could potentially identify risk markers as early as 12 months of age.

As noted in a systematic review published in Cureus, atypical gaze patterns join other early behavioral markers like reduced eye contact and differences in social smiling that may signal autism risk in infancy.

Practical Considerations and Limitations

While promising, researchers caution that eye-tracking isn't yet ready to serve as a standalone diagnostic tool. Current studies show it works best as part of a broader screening approach. The 2025 Springer study reported 82% sensitivity but noted this varied by age, with lower accuracy under 18 months. Questions also remain about how well these methods work across diverse populations, as most research has focused on Western, high-income settings.

The nursery study's broad age range (7-48 months) means more research is needed to refine protocols for specific age groups. As highlighted in Frontiers research, developmental trajectories vary significantly in early childhood. Still, the ability to implement screening in community settings marks significant progress toward making early detection more accessible.

For families receiving screening results, experts recommend follow-up with developmental specialists rather than drawing conclusions from eye-tracking alone. Early indicators should always be considered alongside comprehensive clinical evaluation.